[The transurethral microwave thermotherapy of benign prostatic hyperplasia].
Treatment outcomes are available for 502 patients with benign prostatic hyperplasia exposed to transurethral microwaves (TUMW) on Prostatron unit. Of the patients whose age ranged from 55 to 84, 328 had stage I disease, the rest stage II. 32 patients had previously undergone cystostomy. Acute urine retention was registered in 67 patients on day 1-4 after microwave therapy because of edema of the tumor. To remove the urine, cystostoma and catheter were placed in 18 and 49 patients, respectively. In half a year a positive effect occurred in 80% of cases. As microwave therapy relieves symptoms, increases the quality of life, improves urine flow and reduces the tumor size it can be recommended for the treatment of benign hyperplasia of the prostate.
Neĭmark
A I
AI
Ryzhenkov
S V
SV
Sibul'
I E
IE
D000368:Aged; D000369:Aged, 80 and over; D000772:Anesthesia, Local; D005500:Follow-Up Studies; D006801:Humans; D006979:Hyperthermia, Induced / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods*; D008297:Male; D008872:Microwaves / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000150:complications / Q000628:therapy*; D012074:Remission Induction; D013997:Time Factors; D014521:Urethra
Transuretral'naia mikrovolnovaia termoterapiia dobrokachestvennoĭ giperplazii predstatel'noĭ zhelezy.